Pediatric non-alcoholic fatty liver disease: current perspectives on diagnosis and management
Open Access
- 1 August 2019
- journal article
- review article
- Published by Taylor & Francis in Pediatric Health, Medicine and Therapeutics
- Vol. ume 10, 89-97
Abstract
Non-alcoholic fatty liver disease (NAFLD) represents the most common cause of chronic liver disease in childhood. To date, the “multiple-hit” hypothesis is largely recognized as an explanation of NAFLD pathogenesis and progression. Obesity and features of the metabolic syndrome have been closely linked to NAFLD development. Due to the increased prevalence of obesity worldwide, NAFLD has reached epidemic proportions over time. Given its unfavorable cardiometabolic burden (such as cardiovascular and metabolic consequences), it represents a worrying phenomenon needing a more comprehensive and successful management. Laboratory tests and classical imaging techniques play a pivotal role in NAFLD diagnosis, but novel noninvasive alternative methods to diagnose and monitor NAFLD have been investigated. Currently, lifestyle modifications remain the mainstay treatment, although its efficacy is poor because of the lack of compliance. Pediatric research is focusing on multiple alternative treatments targeting the main pathogenic factors such as insulin-resistance, dyslipidemia, gut-liver axis and microbiota, oxidative stress, and proinflammatory pathways. Results from these studies are promising but larger validation is needed. Innovative therapeutic approaches might add an important piece in the complex knowledge of pediatric NAFLD. We aimed to summarize recent insights into NAFLD diagnosis and treatment in children, with a focus on possible future perspectives in pediatric research.Keywords
This publication has 83 references indexed in Scilit:
- More on Current Evidences on Probiotics as a Novel Treatment for Non-Alcoholic Fatty Liver DiseaseHepatitis Monthly, 2013
- Diagnosis of Nonalcoholic Fatty Liver Disease in Children and AdolescentsJournal of Pediatric Gastroenterology and Nutrition, 2012
- Biochemical Parameters and Anthropometry Predict NAFLD in Obese ChildrenJournal of Pediatric Gastroenterology and Nutrition, 2011
- Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and AdolescentsJAMA, 2011
- A Combination of the Pediatric NAFLD Fibrosis Index and Enhanced Liver Fibrosis Test Identifies Children With FibrosisClinical Gastroenterology and Hepatology, 2011
- The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 yearsGut, 2009
- The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver diseaseBMC Medicine, 2009
- Orlistat for overweight subjects with nonalcoholic steatohepatitisHepatology, 2009
- A Double-Blind Randomized Placebo-Controlled Trial of Orlistat for the Treatment of Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2006
- Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy†Hepatology, 2005